Jun 2025· IEEE transactions on computational biology and bioinformatics· Vol PP· 1 citation· 45 references
BiologyComputer ScienceMedicine
Abstract
Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution. However, most existing approaches frame molecular generation as an isolated optimization or a one-to-one matching task, overlooking the shared binding patterns and intrinsic similarities among protein-ligand complexes. This fragmented perspective constrains their ability to capture the fundamental principles governing molecular recognition and binding specificity. Moreover, the limited availability of high-quality experimental data further hampers model generalization and real-world applicability. To address these challenges, we present READ, a retrieval-alignment molecular generation framework that conditions the generative process on small molecules targeting homologous proteins. Retrieved ligands are aligned with a diffusion model across multiple representational spaces and integrated as conditional guidance throughout successive stages of generation. Under a standardized docking-based evaluation protocol, READ achieves consistently strong performance against state-of-the-art SBDD methods. More importantly, it introduces a retrieval-alignment paradigm for structure-based molecular generation, offering a practical framework for early-stage computational hit generation while leaving prospective experimental validation as future work.
A clear pattern is revealed in LLM spatial capabilities: while they still lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously, enabling scaling to heterogeneous setups.
Thomas MacDougall, Maksim Kuznetsov, Roman Schutski et al.· arXiv.org· 1 citation
Accurate prediction of drug-target binding affinity (DTA) is a key task in virtual screening. However, current computational methods face a key challenge: sequence-based approaches often fail to capture critical spatial information, while structure-based models rely on computationally expensive 3D coordinates, which re...
Junlin Xu, Ye Yuan, Menglong Hu et al.· IEEE journal of biomedical a...· 0 citations
Current structure-based drug design generative models often struggle to faithfully recapitulate genuine ligand-protein binding interactions. Instead, under the coupling of implicit learning architectures and biased training data, they tend to learn spurious statistical correlations. To address this, we propose EIP-Diff...
Huabin Du, Mingyang Wang, M. Luo et al.· Journal of the American Chem...· 0 citations
Protein-ligand binding affinity (PLA) prediction aims to guide rational drug design by estimating the strength of interaction. The effectiveness of the representation learning of protein and ligand is key to successful PLA prediction. To this end, attention mechanism, as a powerful architectural paradigm, has been intr...
Changming Yao, Shunfanyi Li, Shanghui Deng et al.· IEEE transactions on computa...· 0 citations
The resulting model, HydrAffinity, is an interaction-free, dynamic sparse model that uses pre-trained encoders and MoE for parameter-efficient learning and outperforms all interaction-free methods and matches state-of-the-art interaction-based methods on CASF-2016.
This work takes PROTAC linker design as a representative case where data scarcity, multi-constraint satisfaction, and interpretability requirements simultaneously hold, and provides quantitative evidence of distributional mismatch between PROTAC linkers and general small-molecule linkers.